Trials / Terminated
TerminatedNCT02737930
Fluoxetine for Visual Recovery After Ischemic Stroke
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Bogachan Sahin · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether fluoxetine, a selective serotonin reuptake inhibitor commonly used for depression, enhances visual recovery after an acute ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluoxetine | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
- First posted
- 2016-04-14
- Last updated
- 2021-10-13
- Results posted
- 2021-10-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02737930. Inclusion in this directory is not an endorsement.